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ABSTRACT 
Objective: Curcumin (CUR), the active ingredient in turmeric has been proven to possess many therapeutic activities chiefly as anti-inflammatory 
and antioxidant. Unfortunately, CUR suffers from low bioavailability and dissolution due to its poor water solubility. The aim of this work was to 
enhance the dissolution of CUR by converting it into an amorphous form by freeze-drying and using different carriers. 
Methods: Different solid dispersions of CUR with Inulin and Neusilin US2 at different ratios using the freeze-drying technique were prepared. The 
various prepared formulas were characterized using differential scanning calorimetry, X-ray diffraction studies, fourier transform infrared and 
scanning electron microscopy. Release studies, as well as stability studies of CUR from different formulas, were done. 
Results: Formulation containing CUR, Inulin and Neusilin US2 at a ratio of 1:5:1 showed the highest CUR release during dissolution testing. The 
percent CUR release was 98% in comparison with that of 2% from the reference raw material. Physical stability testing showed that CUR remained 
in the amorphous state for 3 mo. 
Conclusion: Inulin and Neusilin US2 combinations were found to be effective in enhancing the solubility and dissolution rate of CUR, and stabilizing 
the amorphous form in the prepared solid dispersion. 
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CUR is the main curcuminoid of the turmeric spice (curcunin longa), 
which is a member of the Ginger family (Zingiberaceae). Other 
curcuminoids present are desmethoxycurcumin and bis-desmethoxy 
curcumin. These curcuminoids which are polyphenols gave turmeric the 
yellow color. That is why turmeric is used as a yellow food colorant and 
food additive [1]. CUR has been used for many years due to its 
therapeutic activities, such as anti-inflammatory, antioxidant, 
antimicrobial, peptic ulcer healing and anti-cancer [1-7]. CUR suffer from 
low aqueous solubility due to its lipophilicity. Its solubility is about 3.12 
mg/l at 25 °C. As consequence of its low solubility, CUR exhibits poor 
dissolution and bioavailability properties limiting its clinical use and 
enlarging the administered dose to 8-12g daily. Despite of the high 
administered dose, CUR plasma concentration was less than 1 µg/ml and 
this concentration has no therapeutic activity [8-10]. CUR structure 
present in fig. 1a demonstrates the lipophilic nature of CUR. 
Many attempts were carried out to enhance the aqueous solubility of 
CUR. For example, solid dispersion of CUR with PVP using the spray 
drying technique was carried out. This led to an increase in the 
dissolution rate as compared with pure CUR [11]. Other methods include 
freeze-drying of CUR with Eudragit solution [12], formulation of oil in 
water nanoemulsion (o/w) [13], the use of nanoparticles [14] and the 
use of antisolvent technique [15]. Most of these techniques have many 
limitations such as the use of expensive solvents, the high production 
cost, poor stability, and the leaky nature of some of the carriers use. 
These findings the need to further enhance the dissolution properties of 
CUR that overcome the drawbacks of the previous methods.  
One of the most promising techniques to improve CUR solubility is 
preparing it in the amorphous form by freeze drying [10, 16]. It is 
well known that the amorphous form has higher aqueous solubility 
and dissolution characteristics than the corresponding crystal form. 
In addition, spray drying produces a very small particle size product. 
The main drawback of this method is the physical instability due re-
crystallization. Several additives have been used to stabilize the 
amorphous form of CUR such as Maltodextrin [17],PVP [10], HPMC 
[16], Gelucire–Aerosol combination [18]. The use of such additives 
showed some enhancement in stability. However, stability 
enhancement was not sufficient with some agents or the 
improvement of CUR solubility was limited. 
One of the most valuable carriers that shows to be the high capability 
of stabilizing the amorphous form of many drugs is Neusilin US2. 
Neusilin US2 is a highly porous synthetic amorphous polymer with 
large surface area. It consists of a tetrahedron of silicon, octahedron of 
magnesium and either tetra or octahedron of aluminum. Fig. 1b shows 
the structure of Neusilin. Because of the high surface area and the 
porous structure, it can adsorb high amounts of oils or water and can 
be compacted into tablets or used as a carrier in solid dispersions by 
forming hydrogen bonds with the adsorbate [19-24]. 
Another substance that has been used to improve the solubility and 
dissolution of many drugs is Inulin. Inulin is a surfactant capable of 
improving the solubility of many drugs and has been used as carrier 
in solid dispersion. In addition, Inulin was used to stabilize 
amorphous drug by acting as coating additive. Inulin is a natural 
polysaccharide prebiotic that can be obtained from many plants 
such as Cichorium intybus (Chicory) and Helianthus tuberosus 
(artichoke). It does not get metabolized in the GIT of human as 
glucose, sucrose and lactose. The structure of inulin is shown in fig. 
1. C. since Inulin is a prebiotics, it stimulate the growth of beneficial 
bacteria in the colon. Because of this, Inulin has been proven to be a 
flexible substance in different applications [25-30]. 
The main objective of this research is to prepare a stable amorphous 
form of CUR to enhance its dissolution and bioavailability properties 
using the freeze-drying technique. Because the amorphous form is not 
stable and tends to recrystallize due to its high internal energy, two 
carriers were used to prevent recrystallization namely: Inulin and 
Neusilin US2. Neusilin US2 has a high surface area and a porous 
character, it will entrap CUR and prevent its crystallization. Inulin is 
proposed to enhance the pharmacological effect of CUR by increasing its 
solubility and stabilization of the amorphous form through surface 
coating. The influence of carrier concentration on the dissolution and 
physicochemical properties were investigated, and the optimum formula 
having the highest dissolution rate was selected for further tests. 
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Fig. 1: A) Curcuminoids structure, (B) Neusilin US2 structure, (C) Inulin structure 
 
MATERIALS AND METHODS  
CUR was obtained from Acros Organics-Fisher, Belgium (Purity: 
98%, melting point: 180 °C). Neusilin US2 was obtained from Fuji 
Chemical, Japan. Inulin Dahila Tubers was obtained from Santa Cruz 
Biotechnology, USA. Absolute ethanol was obtained from Carlo Erba-
Italy. DPPH (2, 2-diphenyl-1-picrylhudrazyl) free radical was 
obtained from Sigma, Aldrich, USA. Distilled water used in all 
experiments and all chemicals were used as received without 
further modification. 
Preparation of the solid dispersion 
CUR sample of 150 mg was dissolved in 50 ml absolute ethanol and 
stirred at room temperature. The mixture was then added stepwise 
to 50 ml aqueous solution containing the carrier (Neusilin US2 
and/or Inulin). The concentrations of the carriers were varied as 
present in table 1. 
The mixture was stirred for 5 min. Then, ethanol was removed from the 
suspension by Heidolph rotary evaporator. Evaporation was carried out 
at 70 °C under vacuum and the rotational speed of 30 round/min for 10 
min. Telstar lyo Quest freeze-dryer was then used to get rid of water. 
Freeze drying was performed at temperature of-80 °C and pressure of 
0.3 mTorr Pressure. The product remained in the freeze dryer for 2 d. 
After processing, the prepared solid dispersions were kept in the dry 
state and stored in tightly closed amber containers. 
Preparation of the physical mixture 
A physical mixture of CUR with Neusilin and Inulin were prepared 
by mixing a specific amount of CUR with the carriers as shown in 
table 1. The samples were stored in a tightly closed amber container. 
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Table 1: The prepared CUR dispersions and physical mixtures that contain Inulin and/or Neusilin at different ratios 
Formulation Preparation method CUR (mg) Inulin (mg)) Neusilin (mg) CUR: Inulin: Neusilin ratio 
SD (1:1;0) Freeze-dry 30 30 0 1:1:0 
SD (1:0:1) Freeze-dry 30 0 30 1:0:1 
SD (1:5:0) Freeze-dry 30 150 0 1:5:0 
SD (1:0:5) Freeze-dry 30 0 150 1:0:5 
SD (1:1:1) Freeze-dry 30 30 30 1:1:1 
SD (1:5:1) Freeze-dry 30 150 30 1:5:1 
PM (1:5:0) Physical mix 30 150 0 1:5:0 
PM (1:1:1) Physical mix 30 30 30 1:1:1 
PM (1:5:1) Physical mix 30 150 30 1:5:1 
PM (1:0:1) Physical mix 30 0 30 1:0:1 
CUR Pure 30 0 0 - 
Note: Three batches were prepared from each formulation  
 
Characterization of solid dispersion 
X-ray diffraction (XRD) 
XRD was performed at room temperature using Ultima XRD (Rigaku, 
Japan) with cobalt radiation (CuKa) at 40kV and current of 30 mA. 
The scan range was set from (0-40 °) 2θ diffraction angle at step size 
of 0.02 °. 
Differential scanning calorimetry (DSC) 
Differential scanning calorimetry was done using (Netzsh-DSC, 
Netzsh, Germany) connected to a liquid nitrogen chamber for 
cooling. The entire enthalpy process was calibrated by indium. 
Sample of 5 mg of raw materials, physical mixture or solid 
dispersion was accurately weighed and heated in a sealed aluminum 
pan under stream of nitrogen gas. The sample scan range was 40-
200 °C at a rate of 5 °C/min. 
Fourier transform infrared (FTIR) 
FTIR spectra of all raw materials, the physical mixture and the solid 
dispersion were acquired using FTIR (Shimadzu, Japan) and KBr as a 
reference. About 5 mg of each sample was mixed with KBr and then 
scanned. The FTIR scan range was between 400 and 4000 cm-1. 
Dissolution tests 
Dissolution tests of pure CUR, the physical mixture and the solid 
dispersion were performed in Apparatus II dissolution tester (RC-
8DS, Tianjin Guoming medicinal equipment, China). The rotational 
speed of the paddles were set at 50 rpm. The volume of dissolution 
media was 900 ml. The dissolution medium was 0.25% w/v sodium 
lauryl sulfate (SLS). This media was selected to maintain the sink 
condition. The temperature was kept at 37±0.05 °C. Samples 
containing an equivalent amount of 30 mg CUR were tested. At 
predetermined time intervals, samples of 5 ml were withdrawn and 
an equal volume of fresh media was added to maintain the volume of 
the dissolution media. The withdrawn samples were filtered through 
cellulose membrane then diluted with the dissolution media and the 
concentration of CUR was determined using UV/VIS 1800 
spectrophotometer (Shimadzu, Japan) at λmax 430 nm. All 
experiments were done in triplicate [31]. 
Physical stability testing 
To evaluate the effect of temperature and humidity on the stability 
of the amorphous form, samples of the prepared solid dispersion 
were placed in vials and stored at 40±2 °C and 75% relative 
humidity in (Schutzart-Mermmert stability chamber, Germany). 
After 3 mo samples were withdrawn. The samples were analyzed 
using XRD, DSC to evaluate the stability of the amorphous form of 
CUR. Dissolution testing of the samples was also conducted as 
discussed earlier. 
Antioxidant test 
The antioxidant test was performed by DPPH free radical assay. The test 
was done for the prepared solid dispersion and raw CUR. This done to 
determine if CUR activity on scavenging free radicals was affected by the 
preparation method of solid dispersion. About 1.5 mg of DPPH (2,2-
diphenyl-1-picrylhudrazyl) was dissolved in ethanol and analyzed using 
UV spectrometer at λmax 517 nm to obtain the absorbance of the blank. 
Then 0.5 ml of the blank solution was added to 1.5 ml of ethanolic 
solution of CUR at different concentrations (20-100 µg/ml) (n=3), 
incubated in the dark for 15 min and then analyzed at λmax 517 nm to 
obtain the absorbance of the mixture. The antioxidant activity was 
expressed as AA% based on the following equation:  
 
RESULTS AND DISCUSSION 
Preliminary dissolution testing studies were conducted on the various 
formulation mentioned in table 1. Of the solid dispersion formulations, 
solid dispersion formula (SD 1:5:1) was found to produce the highest 
CUR release. Almost complete dissolution (98%) was achieved within 
one hour. The release of the other formulations was substantially less 
than that. The range of percent release within one hour was (26.55%-
90.6%). The percent release of pure CUR within one hour was 22.9%. 
Solid dispersion formula (SD 1:5:1) was considered the best formula 
and selected for thorough investigations. 
X-ray diffraction 
XRD patterns for the raw materials and the prepared solid 
dispersion (SD 1:5:1) are shown in fig. 2. In fig. 2, pure CUR showed 
several characteristic peaks between 10 and 30 (2-theta) which 
indicate a highly crystalline material. The major peaks of CUR were 
observed at angles 14.56, 17.16 and 21.05 ° which is similar to what 
was previously reported [32]. Inulin shows peaks between 10 and 
25 (2-theta) which is related to its crystalline nature. Meanwhile, 
Neusilin did not show any peaks as it is an amorphous substance. 
By comparing the same ratios of the two formulas of CUR, one prepared 
by solid dispersion while the other is the physical mixture of the same 
components, it appears that the physical mixture retained the same 
crystalline peaks of its components while in the solid dispersion CUR 
peaks disappeared. This indicates that CUR prepared by freeze drying 
and dispersed in the carrier is present in the amorphous form. 
Differential scanning calorimetry (DSC) 
The DSC thermograms of raw materials are shown in fig. 3. CUR 
shows a sharp endothermic peak at 180 °C. These findings are in 
agreement with previously reported study[33]. This sharp melting 
peak indicates that pure CUR exists in the crystalline state. Inulin 
showed an endothermic peak at 169.5 °C. This peak is related to the 
melting of the substance. Meanwhile, Neusilin did not have any 
endothermic peak due to it amorphous nature. 
Fig. 3 also shows the DSC thermogram for the prepared solid 
dispersion (1:5:1). CUR in this formulation did not show any 
endothermic peak at 180 °C. This finding suggests that CUR is 
present in its amorphous form. On the other hand, the 
corresponding physical mixture of the same ratio showed two 
endothermic peaks. The first peak at 169 °C corresponds to the 
melting point of Inulin while the other peak at 169.5 corresponds to 
the melting of the CUR. The presence of these peaks in the physical 
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mixture indicates that CUR is present in crystalline form. The DSC 
Data support the results obtained by XRD data. 
Finally, based on the XRD and DSC tests, it was concluded that CUR 
in the prepared solid dispersion was in the amorphous state. 
 
 
Fig. 2: I-shows the XRD pattern for the prepared solid dispersion (SD 1:5:1), Neusilin, Inulin and pure CUR. II-shows the XRD of pure CUR, 
physical mixture and solid dispersion (SD 1:5:1) 
 
 
Fig. 3: DSC thermograms of pure CUR, Neusilin, Inulin and solid dispersion (SD 1:5:1) and the corresponding physical mixture 
 
Fourier transform infrared (FTIR) 
FTIR analysis was performed to provide structural information about 
the used materials and to detect the presence of any possible 
interactions between the drug and the carriers. These interactions are 
detected by any changes in the position or disappearance of a 
characteristic vibration or stretching region of the compound. FTIR 
spectra of CUR is shown in fig. 4. CUR shows a characteristic peak at 
3450 cm-1 due to OH group stretching and a peak at 1650 cm-1 due to 
carbonyl functional group (C=O). Any interaction between CUR and the 
carriers is revealed by changing in the carbonyl peak position. FTIR of 
raw materials and solid dispersion (SD 1:5:1) are presented in fig. 4. The 
FTIR analysis of the physical mix and the solid dispersion shows that the 
C=O stretching of CUR was slightly shifted to a lower wavelength and the 
OH stretching peak disappeared. This change is attributed to the dilution 
effect of the carriers and hydrogen bonding between CUR and both 
carriers. Meanwhile, the physical mixture shows no change compared to 
the pure CUR other than dilution by the carriers. 
 
 
Fig. 4: FTIR spectra of CUR, Inulin, Neusilin, solid dispersion (SD 1:5:1) and the corresponding physical mixture 
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An in vitro study was performed to find out if the amorphous form of 
CUR in a mixture of Inulin and/or Neusilin US2 can improve the 
dissolution rate and enhance the total amount of drug dissolved in the 
media. The dissolution profile of the optimum solid dispersion (SD 
1:5:1) was compared with the corresponding physical mixture and the 
pure crystalline CUR. Fig. 5 shows the dissolution profiles of pure CUR, 
the solid dispersion (SD 1:5:1) and the corresponding physical 
mixture. During the dissolution testing, freshly prepared samples were 
studied. After 1 hour in the dissolution media, the order of percent 
release was as follows; pure CUR<physical mixture<solid dispersion 
where pure CUR samples were able to release only 23% in comparison 
with 37.8% for physical mixture and 98% for the solid dispersion. 
Many factors could contribute to this result. Primarily, CUR is present 
in the amorphous state in the solid dispersion. XRD and DSC results 
confirmed the amorphous state of CUR in the prepared solid 
dispersion. Secondly, the prepared solid dispersion showed better 
flowability and lower agglomeration potential. This is attributed to the 
fact that Neusilin US2 is a highly porous spherical particle with a large 
surface area. This leads to more contact points with the dissolution 
media and the drug. In addition, the solid dispersion formula had 
better wettability due to the fact that Inulin is a surface active agent. 
Inulin was also reported to enhance the dissolution and solubility of 
drugs by coating drug particles and enhancing wettability [26, 28-30]. 
Thus, it was concluded that preparation of CUR solid dispersion in a 
carrier combination of Inulin and Neusilin by freeze drying has 
resulted in a vast improvement in the dissolution properties of CUR. 
This formula is expected to improve the oral bioavailability of CUR as 
compared with the raw CUR. 
Physical stability testing 
Most amorphous drugs in solid dispersions tend to recrystallize at 
high temperature and humidity. To evaluate the effect of aging on 
the performance of amorphous CUR in the solid dispersion formula, 
a three-month accelerated stability study was performed. It is 
known that the stability of the amorphous state is affected by the 
storage temperature and the humidity, which can influence and 
affect the recrystallization rate [34]. The rate of recrystallization 
usually accelerated with the increase in temperature and humidity. 
Consequently, storage conditions were selected to be 40 °C/75%RH 
to evaluate their influence on the solid state stability of the prepared 
solid dispersion. These conditions are frequently used during 
accelerated stability studies of pharmaceutical products. 
The optimum solid dispersion formula (SD 1:5:1) was selected to be 
tested for aging as it has the fastest dissolution rate and contains an 
amorphous form of the drug. DSC and XRD were used to evaluate the 
influence of the storage conditions on the stability of solid form of 
CUR in the solid dispersion. The influence of aging on the in vitro 
drug release was also evaluated. 
XRD, DSC, and dissolution profile results after storage for 3 mo in the 
stability chamber are shown in fig. 6 along with the results for the 
freshly prepared samples. Fig. 6-I shows the XRD data for the freshly 
prepared and aged sample of solid dispersion (SD 1:5:1). The two 
XRD profiles are identical. No peak has appeared. These findings 
indicate that CUR in the solid dispersion remained in the amorphous 
form and there is no sign of any crystallization is taking place. DSC 
data after aging, presented in fig. 6-II, did not show any endothermic 
peak at 180 °C related to the melting point of crystalline CUR. This 
indicates that CUR in solid dispersion remained in the amorphous 
form. These results go along with XRD data. The DSC thermogram of 
aged solid dispersion sample shows a broad peak around 90 °C. This 
peak is linked to the evaporation of water present in the sample as it 
was stored in the humid environment. Water uptake by the samples 
verifies the high hydrophilicity and wettability of the prepared solid 
dispersion. The results of the in vitro dissolution testing exist in fig. 
6-III for the solid dispersion formula (SD 1:5:1) before and after 
storage in the stressed condition for 3 mo. The results showed that 
the percent drug release after one hour of dissolution testing was 
97.5% for the aged sample in comparison with 98% for the freshly 
prepared solid dispersion. Statistical testing reveals that the 
difference between the two values was insignificant. 
Overall, it can be concluded that CUR in the solid dispersion formula 
(SD 1:5:1) was physically stable and Inulin and Neusilin were 
capable of preventing the conversion of CUR from the amorphous 
state into the crystalline state and were capable of preserving the 
dissolution profile of CUR for three months under the harsh 
condition of elevated temperature and humidity. 
Antioxidant test 
Antioxidant test by DPPH free radical assay was performed on both 
pure CUR and the selected optimum solid dispersion formula (SD 
1:5:1). This test determines if the solid dispersion technique and the 
additives used during preparation have any effect on the free radical 
scavenging activity of CUR. In general, DPPH (1,1-Diphenyl-2-picryl-
hydrazyl) is a free radical that act as a trap “scavenger "for other 
chemicals. Interactions of DPPH with other chemicals are used as an 
indicator of the antioxidant activity of the chemical. DPPH has a 
strong absorption peak at 517 nm, giving it a deep violet color in 
solution. Interaction of DPPH with other compounds leads to change 
of the color from violet to pale yellow during antioxidant activity 
tests due to the neutralization of the free radical. CUR is used as an 
antioxidant to treat many inflammatory diseases. To ensure that the 
antioxidant activity of CUR in the solid dispersion formulation, 
antioxidant activity test was performed using DPPH. The intensity of 
color of the solution was estimated by measuring the absorbance using 
UV at 517 nm. Fig. 7 shows the antioxidant test for the prepared solid 
dispersion (SD 1:5:1) and pure CUR. Fig. 7. I, compares the absorbance 
of the ethanolic solution of DPPH in the presence of different 
concentrations of CUR as a pure form and in the solid dispersion 
formulation. The profiles of the two CUR forms were identical 
indicating the same interaction with DPPH. Fig. 7. II, compares the 
antioxidant activity of CUR present as pure form and in the solid 
dispersion formulation with varying concentrations of CUR. The same 
conclusion was obtained that CUR activity in the solid dispersion 
formulation did not altered by preparation method of additives used. 
 
 
Fig. 5: Dissolution profiles of CUR, physical mixture and solid dispersion (SD1:5:1) (mean±SD, n=3) 
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Fig. 6: (I) XRD pattern of (a) freshly prepared solid dispersion (SD 1:5:1) (b) aged solid dispersion (SD1:5:1) after 3 mo of storage in 40 °C 
and 75%RH. (II) DSC thermograms of (a) Freshly prepared solid dispersion (SD 1:5:1) (b) Aged solid dispersion (SD 1:5:1) after 3 mo of 
storage in 40 °C and 75%RH. (III) Release profile of freshly prepared solid dispersion (SD 1:5:1) and aged solid dispersion (SD 1:5:1) after 
3 mo of storage in 40 °C and 75% RH (mean±SD, n=3) 
 
 
Fig. 7: (I) Effect of different concentrations of CUR pure or in solid dispersion (SD 1:5:1) on absorbance of DPP.(II)Scavenging effect of 
pure CUR pure or in solid dispersion (SD 1:5:1) on DPPH at different concentrations (mean±SD, n=3) 
Taani et al. 




The findings clearly show that preparing CUR in solid dispersion by 
the freeze-drying technique was successful in improving the 
dissolution properties of CUR. Combinations of Inulin and 
NeusilinUS2 in the solid dispersion were capable of preserving the 
amorphous form of CUR in the formulation. The optimized solid 
dispersion did not only preserve the release properties but also 
maintained the antioxidant activity of CUR. This formulation is 
expected to be an effective delivery system for CUR. 
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